This paper optimized a Trizol extraction protocol and real-time PCR annealing temperatures for extraction of microRNA (miRNA, miR) from plasma and investigated whether five miRNAs could be used as biomarkers for acute myocardial infraction (AMI).
Screening of miRNAs in plasma as a diagnostic biomarker for cardiac disease based on optimization of extraction and qRT-PCR condition assay through amplification efficiency.
Ban E, Kwon H, Seo HS, Yoo YS, Song EJ
Purpose
Conclusion
Amplification of miR-16 and cel-miR-39 were linear (R2>0.99) at all tested annealing temperatures, but the quantification cycle (Cq) values and efficiency were affected, as the highest amplification efficiency was achieved at 65°C and 60°C, respectively. Amplification efficiency was within the recommended range when miRNA was precipitated from 200-400 µL of the aqueous phase of the sample but use of 500 µL resulted in higher PCR efficiency which was indicative of interference. The presence of residual phenol was reduced when RNA was subjected to triple chloroform extraction or an ethanol wash after precipitation, but both steps also reduced total RNA yield. The lowest Cq value for miR-16 was achieved after using a triple chloroform extraction without an ethanol wash. Using the optimized PCR protocol, non-significant differences in plasma levels of miR-16, miR-132, miR-155, and miR-499 were identified between patients with myocardial infarct and age-matched controls.
Studies (1)
Purpose
This paper optimized a Trizol extraction protocol and real-time PCR annealing temperatures for extraction of microRNA (miRNA, miR) from plasma and investigated whether five miRNAs could be used as biomarkers for acute myocardial infraction (AMI). Commercially obtained, pooled human plasma from healthy donors and the plasma from six healthy individuals (details of collection not provided) were mixed with Trizol LS and spiked with cel-miR-39 before the addition of chloroform. To identify the ideal volume of the aqueous phase that yields the highest amount of miRNA in the absence of phenol contamination, 200, 300, 400 µL, and 500 µL of the aqueous phase were transferred to new tubes for isopropanol precipitation. To investigate the best way to reduce residual phenol, chloroform washing was performed 1 or 3 times before isopropanol precipitation. RNA was precipitated in isopropanol at -80°C for 1 h, the specimen was centrifuged at 20,000 g for 30 min at 4°C. The pellet was then washed in 70% ethanol or directly resuspended in RNAse Free water. Additional RNA was extracted from the plasma of 5 male patients with AMI (age 52-60 years, mean 55.3 years) and 3 male patients without a history of cardiovascular, renal or hepatic diseases or malignancy (age 52-59 years, mean 57 years). RNA concentration and phenol contamination were measured by NanoDrop with the Acclaro Contaminant Identification feature. RNA was reverse transcribed using Mir-X miRNA First Strand Synthesis kit and miRNA-16, miR-21, miR-132, miR-155, and miR-499 were quantified by real-time PCR using a range of annealing temperatures. Efficiency was calculated based on standard curves.
Summary of Findings
miR-16 and cel-miR-39 amplification were linear (R2>0.99) at all tested annealing temperatures, but the Cq values decreased with increasing temperature. The highest amplification efficiency achieved was 97.6% at 65°C for miR-16 and 91.2% at 60°C for cel-miR-39. The amplification efficiency was within the recommended range when miRNA was precipitated from 200-400 µL of the aqueous phase but use of 500 µL resulted in higher PCR efficiency, indicating interference. The presence of residual phenol was reduced when RNA was subjected to triple chloroform extraction or an ethanol wash after precipitation, but both steps also decreased total RNA yield. A significantly lower Cq value for miR-16 was achieved using a triple chloroform extraction without an ethanol wash than was achieved using a single chloroform extraction with an extra ethanol wash (P=0.0289). Using the optimized PCR protocol, non-significant differences in plasma levels of miR-16, miR-132, miR-155 and miR-499 were identified between patients with myocardial infarct and age-matched controls.
Biospecimens
FluidPlasmaPreservation Types
FrozenDiagnoses
Cardiovascular DiseaseNormalNot specifiedPlatforms
RNAReal-time qRT-PCRRNASpectrophotometryPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Control patientMyocardial infarct patientAnalyte Extraction and Purification Analyte purification Trizol with one chloroform extractionTrizol with three chloroform extractionsAnalyte Extraction and Purification Washing No additional washingWashed in ethanolReal-time qRT-PCR Specific Nucleic acid amplification Anneal at 58°CAnneal at 60°CAnneal at 62°CAnneal at 65°CAnneal at 67°C